Importance of NGS testing for STK11 and KEAP1 mutation and impact on treatment selection

Faculty: Charu Aggarwal, MD, MPH, Biagio Ricciuti, MD, PhD
Disclosures

Download Slides

Panelists

Charu Aggarwal, MD, MPH

Physician Leader, Airways Malignancies Research Director
Precision Oncology Innovation, Penn Center for Cancer Care Innovation
Section Chief, Head & Neck and Thoracic Cancers, Hematology-Oncology
Leslye M. Heisler Professor for Lung Cancer Excellence
Penn Medicine

Biagio Ricciuti, MD, PhD

Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Department of Medicine
Harvard Medical School

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading